ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 789–795
DOI: 10.46882/AJIDR/148876
Article Type: Original Article
Title: Seroepidemiology and clinical outcomes of yellow fever virus infection during sylvatic-to-urban spillover surveillance
Names of Authors: Kwame Boateng¹*, Sophie Laurent², Rafael Silva³
Authors’ Affiliations: ¹Department of Virology, Noguchi Memorial Institute for Medical Research, Accra, Ghana. ²Emerging Arboviruses Unit, Pasteur Institute, Paris, France. ³Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.
Abstract: Yellow fever virus poses recurring epidemic threats when sylvatic transmission cycles spill over into unvaccinated peri-urban populations. We evaluated acute yellow fever incidence, neutralizing antibody levels, and clinical severity predictors among febrile jaundice patients. Serum samples from 350 suspected cases were tested via IgM capture enzyme-linked immunosorbent assay, plaque reduction neutralization testing, and reverse transcription polymerase chain reaction. Acute yellow fever was confirmed in 11.4 percent of patients, exclusively among unvaccinated individuals, with elevated aspartate aminotransferase and renal dysfunction predicting mortality. Catch-up fractional-dose vaccination campaigns and Aedes vector control are critical.
Keywords: Yellow fever virus, Arbovirus surveillance, Viral hemorrhagic fever, Immunization coverage, Flavivirus
Citation: Boateng K, Laurent S, Silva R (2025). Seroepidemiology and clinical outcomes of yellow fever virus infection during sylvatic-to-urban spillover surveillance. African Journal of Infectious Diseases Research, 12(9): 789–795. DOI: 10.46882/AJIDR/148876
Manuscript Timeline: Received: July 30, 2025; Revised: August 30, 2025; Accepted: September 11, 2025; Published: September 18, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read